Literature DB >> 4002116

Beneficial effect of allopurinol in liver ischemia.

G Nordström, T Seeman, P O Hasselgren.   

Abstract

The effect of allopurinol on protein synthesis, tissue water, and adenine nucleotides in liver tissue during and after a period of liver ischemia was investigated in rats. Ischemia was induced in the left and median liver lobes for 1 hour and experiments were continued for 2 hours after reperfusion. One group of animals (n = 20) received allopurinol (50 mg/kg body weight) intravenously 10 minutes before induction of liver ischemia. Control rats (n = 20) were given a corresponding volume of saline solution. Protein synthesis was measured by determining the rate of amino acid incorporation into protein in incubated liver slices. The reduction of protein synthesis and energy level in liver tissue and the increase of hepatic tissue water were similar in both groups of animals at the end of the ischemic period. During reperfusion the protein synthesis rate was higher and hepatic tissue water was lower in allopurinol-treated animals than in control rats. No significant differences in hepatic adenine nucleotides were found between the two groups of rats during ischemia or after reperfusion. The results demonstrated that improved protein synthesis and reduced tissue water in the postischemic liver after administration of allopurinol were not the result of improved restoration of adenine nucleotides. Inhibited production of oxygen-free radicals might be one mechanism by which allopurinol exerted its beneficial effect after liver ischemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4002116

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  26 in total

Review 1.  Inhibition of xanthine oxidase by allopurinol: a therapeutic option for ischaemia induced pathological processes?

Authors:  J G Puig; F A Mateos; V D Diaz
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

Review 2.  Redox therapeutics in hepatic ischemia reperfusion injury.

Authors:  Rakesh P Patel; John D Lang; Alvin B Smith; Jack H Crawford
Journal:  World J Hepatol       Date:  2014-01-27

3.  The role of calcium ions and calcium channel entry blockers in experimental ischemia-reperfusion-induced liver injury.

Authors:  R J Nauta; E Tsimoyiannis; M Uribe; D B Walsh; D Miller; A Butterfield
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

4.  Naloxone pretreatment prevents kidney injury after liver ischemia reperfusion injury.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Mehran Shahzamani; Ahmad Asghari; Aris Fakouri
Journal:  Int Urol Nephrol       Date:  2016-04-07       Impact factor: 2.370

5.  Bile canaliculi are defective in hepatic involvement of organ failure and recovery of liver function is due to their secondary regeneration.

Authors:  E E Douzinas; E Vamvasakis; K Rigas; M Pitaridis; C Kittas; C Roussos
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

6.  Postischemic ATP levels predict hepatic function 24 hours following ischemia in the rat.

Authors:  J Metzger; B H Lauterburg
Journal:  Experientia       Date:  1988-05-15

7.  The effects of allopurinol and SOD on lipid peroxidation and energy metabolism in the liver after ischemia in an aerobic/anaerobic persufflation.

Authors:  T Minor; W Isselhard; Y Yamamoto; M Obara; S Saad
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Influence of pentobarbital and chloralose on metabolic and hemodynamic changes in liver ischemia.

Authors:  G Nordström; O Winsö; B Biber; P O Hasselgren
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

9.  Effects of ischemia and reperfusion on protein synthesis in livers with different glutathione levels.

Authors:  G Nordström; A Säljö; S J Li; P O Hasselgren
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

10.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.